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Sub-millisecond ligand probing of cell receptors with multiple
solution exchange
Sergiy Sylantyev and Dmitri A Rusakov
UCL Institute of Neurology, University College London, London, UK
Abstract
The accurate knowledge of receptor kinetics is crucial to our understanding of cell signal
transduction in general and neural function in particular. The classical technique of probing
membrane receptors on a millisecond scale involves placing a recording micropipette with a
membrane patch in front of a double-barrel (θ-glass) application pipette mounted on a piezo
actuator. Driven by electric pulses, the actuator can rapidly shift the θ-glass pipette tip, thus
exposing the target receptors to alternating ligand solutions. However, membrane patches survive
for only a few minutes, thus normally restricting such experiments to a single-application protocol.
In order to overcome this deficiency, we have introduced pressurized supply microcircuits in the
θ-glass channels, thus enabling repeated replacement of application solutions within 10–15 s. this
protocol, which has been validated in our recent studies and takes 20–60 min to implement, allows
the characterization of ligand-receptor interactions with high sensitivity, thereby also enabling a
powerful paired-sample statistical design.
INTRODUCTION
Background
Activation of cell membrane receptors by extracellular ligands is a fundamental mechanism
of signal transduction in live organisms. More specifically, accurate knowledge of synaptic
receptor kinetics has been crucial to our understanding of how the elementary informative
signals are processed and stored by the neural circuit machinery of the brain. Once a
neurotransmitter has been released into the synaptic cleft, its local concentration initially
peaks and then drops substantially within 200–300 μs. Because this time span is often much
shorter than the characteristic open time of synaptic receptor channels, their activation
typically occurs in conditions of substantial nonequilibrium1-3. Consequently, the classical
kinetic-equilibrium measures, such as the dissociation constant Kd, are unlikely to explain
the synaptic receptor activation kinetics from the local neurotransmitter concentration in the
extracellular space. Indeed, experimental evidence commonly points to a complex
relationship between the time course of individual synaptic responses and the waveform of
the local neurotransmitter transient in central synapses. Therefore, probing receptor
activation on the sub-millisecond time scale should be an important empirical strategy for
obtaining receptor kinetics and the ligand pharmacological profile under conditions that
closely reproduce physiological synaptic events.
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Historical and existing techniques
Three decades ago, several techniques had been developed to provide rapid ligand
application to an excised cell soma or a cell membrane patch. A side-pore perfusion system4
and a single-filament application probe driven by a piezo element5 were described in the
1980s. Subsequently, various experimental systems were implemented that enable
application of multiple solutions to the recorded patch, such as a piezo-driven multicapillary
application pipette6, U-tube perfusion7 or a plumbing flow-exchange method8. Repeated
application of different solutions within the lifetime of a membrane patch (1–5 min) should
be a crucial advantage in many experimental designs: successive pharmacological
manipulations on the same receptor pool (e.g., to document activation, washout, blockade
and so on) are key to the reliable receptor characterization and, in turn, to the development
of pharmacological tools. However, the aforementioned techniques operate with ligand
exposure times exceeding 10–100 ms, which is substantially slower than extracellular
neurotransmitter transients generated locally by small central synapses. To achieve sub-
millisecond application times in excised patches (outside organized tissue), a system was
therefore developed, which relied on a double-barrel (θ-glass) piezo-driven micropipette9-13,
with an estimated time response limit of ~20 μs (ref. 14). Inside organized tissue, fast
application times could be achieved, albeit with little control over precise ligand
concentrations, by using common iontophoretic electrode ejection with a two-pipette
(source-sink) system15, or, more recently, by using rapid photolytic neurotransmitter release
(uncaging)16. It would be important, however, to combine sub-millisecond ligand
application with the capacity of multiple solution exchange. The elegant method of a
hydraulic flow switch17 can in principle provide this combination, but it has some crucial
limitations, especially in experiments involving membrane patches excised from cells in
situ. First, multiple application capillaries are mounted on the objective providing a prefixed
focal plane site where the application takes place17. This must restrict, if not entirely
prevent, microscopic exploration of tissue and selection of target cells in situ. Second, the
method uses aqueous streams flowing from different directions: a rapid switch between such
streams can introduce a mechanical concomitant and shorten preparation lifetime, especially
with relatively bulky nucleated patches (somatic envelopes).
Experimental design
Our aim was to develop a simple technique in which ligand solutions applied with the piezo-
driven θ-glass pipette could be fully replaced during the lifetime of individual cell
membrane patches (1–5 min). To achieve this, we introduced several modifications
described below and termed thereafter a rapid application and solution exchange (RASE)
protocol. The approach has been validated in several of our research publications, as
illustrated below, involving not only the standard outside-out membrane patches but also
larger nucleated patches (nucleus-containing somatic envelopes) that preserve the somatic
milieu in tested cells.
It has been noted previously that, with the θ-glass configuration, the flow velocity has to be
below 100–150 μm ms−1 to avoid damaging the patch and that the optimal pipette tip
diameter must be ~200 μm. Although rapid application relies on the mechanics of the piezo-
driven θ-glass pipette tip movements, the replacement of applied solutions inside the two
barrels depends on rapid solution supply from the back end. The supply could be arranged
by having, inside the barrels, one or more flexible microfilaments connected to a pressurized
microtube circuit. However, this arrangement typically yields a relatively slow rate of
solution exchange, most likely due to a relatively large dead volume (buffering capacity)
inside θ-glass channels, leading to a substantial initial dilution and local vortex formation.
Speeding up the exchange by increasing supply pressure is counteracted by the considerable
viscous resistance in the thin filaments and can also damage the patch. We therefore set out
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to increase the solution exchange rate by reducing the dead solution volume inside the θ-
glass pipette.
Multiple-circuit application pipette—We set out to have three or four supply circuit
microfilaments in each θ-glass channel while maximally reducing the solution exchange
volume (Fig. 1a). To achieve this, we developed the procedure as follows. First, we inserted
three microfilaments in one θ-glass barrel roughly realigning their ends near the pipette tip
(Fig. 1b). Second, we connected a fourth microfilament to a syringe filled with a rapidly
setting, water-resistant glue and inserted it into the same channel (Fig. 1b, image 3).
Pressure was applied to inject the glue into the glass-channel filling before it reached the
three filament ends (Fig. 1b). The procedure was repeated for the other θ-glass barrel (Fig.
1b). Once the glue was set, the pipette was ready for use (Fig. 1c) and could be mounted on
the piezo-actuator attached to a standard microelectrode holder (Fig. 1d) and electrically
connected to a standard constant-voltage stimulus isolator. The pipette mount was made out
of a three-way plastic tubing adaptor, with one branch cut off to provide a channel for the
tightening screw (Fig. 1d, inset).
Pressurized circuit for multiple solution exchange—In the typical configuration,
the solution supply circuit contained three plastic solution containers (from a blood dialysis
kit) for each pipette barrel. Each of these containers was connected to a pressure supply line
and was equipped with three-way taps and a replaceable stopcock (Fig. 2a,b). Two separate
pressure supplies (standard micropumps) were normally required to adjust and equalize
pressure and therefore the ejected stream speed, between the two barrels (which normally
show slightly different hydraulic resistance). Application solutions could be added to each
container independently through a three-way tap with a stopcock removed to siphon the air
inside (Fig. 2a,b). Because switching the solution supply is likely to generate pulses of
excessive pressure, pressure-buffering microfilters were inserted between the solution
container and each loading capillary (Fig. 2c).
Optimizing pipette position and speed—To ensure the fastest possible application
time, the membrane patch needs to be as close as possible to the piezo-driven application
pipette. At the same time, it is important to avoid flow distortions and fluctuations in the
streams when they exit the θ-glass and meet at the end of the glass dividing wall (septum)
(Fig. 3a). We therefore routinely placed a recording pipette at a distance of 20–30 μm from
the tip and further adjusted its position using the water test (Fig. 3b and Supplementary
Video 1). Positioning the patch at some distance from the θ-glass pipette has another
important advantage: because of the brief delay between the θ-glass movement onset and the
time the mechanical wave reaches the recorded patch, there is a clear time lag between the
electrical artifact from the piezo-actuator switch and the actual membrane receptor response
(Fig. 3b). This can be helpful in separating the pulse from the concomitant artifact.
A small piece of silicone inserted into the θ-glass pipette holder under the tightening screw
(Fig. 1d) and the use of shorter pipettes (where possible) can also help in reducing flow
fluctuations (Fig. 3a). The speed at which the application solution switches depends on the
rate of piezo-actuator bending and the length of the application θ-glass pipette attached to it.
This speed could be boosted, at least in theory, either by strengthening the electrical pulse
applied to the piezo actuator or by using longer pipettes (and thus speeding up their tip
movement). In practice, however, increasing the pipette length leads to concomitant
problems such as increased tip vibration and reduced pipette maneuverability. In addition,
longer θ-glass pipettes require longer loading microfilaments, thus increasing viscous
resistance to solution flow.
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Maintaining the correct temperature of the applied solution is important for reliable
characterization of tested receptors. Therefore, in order to ensure temperature equilibration,
the tip of the θ-glass pipette should be submerged into perfusion solution for at least 4–5
mm before starting the recording session. Temperature control in the application streams can
be performed by placing a microthermocouple (e.g., Cole-Palmer Type-K, straight-shaft
microprobe, tip diameter ~100 μm, precision ± 1 °C) at the position of the patch recording
electrode tip.
Experimental validation
The present RASE protocol has been validated in our recent studies, in which cell patches
were excised from acute brain slices, focusing on hippocampal CA1 pyramidal cells18-20,
granule cells21, cerebellar granule cells (CGCs)18,20 and cultured CGCs18. In one
example21, we tested the solution exchange system on its own, by recording single-channel
currents of γ-aminobutyric acid A (GABA)A receptors to establish receptor sensitivity to
GABA and to the common antagonists (Fig. 4a,b). An example from another recent study18
reveals the sensitivity of 2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic acid
(AMPA) receptors to the competitive antagonist γ-D-glutamylglycine when 1 mM–1 ms
pulses of glutamate are applied in a single patch from CA1 pyramidal cells (Fig. 4c).
In a related work, the RASE enabled us to test a hypotheses according to which perisynaptic
group I metabotropic glutamate receptors (mGluRs) could rapidly, on a sub-millisecond
scale, boost local synaptic N-methyl-D-aspartate (NMDA) receptor (NMDAR) currents in
CGCs20. Our experimental objectives thus were to enable receptor probing on a sub-
millisecond scale, to isolate receptor responses from any network influences and to preserve,
as much as possible, the postsynaptic protein machinery. We therefore carried out RASE
experiments in nucleated patches of CGCs (Fig. 5a): we applied a 1-ms pulse of 1 mM
glutamate (plus 1 mM glycine) to compare evoked NMDAR currents between control
conditions and after adding group I mGluR antagonists LY367385 (LY, 100 μM) and 2-
methyl-6-(phenylethynyl)pyridine (MPEP, 200 nM) to both θ-glass barrels (solution
exchange took ~10 s). The NMDAR specificity in the patch was further tested using a third
solution exchange, which added the NMDAR antagonist APV (50 μM). We found that
NMDAR responses to the same pulse, in the same membrane patch, were inhibited by
group-I metabotropic glutamate receptor (mGluR) antagonists (Fig. 5b). This result
indicated that a 1-ms exposure of mGluRs to glutamate was sufficient to boost NMDAR
currents activated by the same glutamate pulse. This effect was not due to contaminant
actions of LY + MPEP or the constituent activity of mGluRs because the same experiment
with NMDA applied instead of glutamate showed no mGluR blockade on NMDARs (Fig.
5c; see further data and detailed explanations in the original research report20).
Advantages and limitations
The principal advantage of RASE is that it allows the application of several different ligands
in a single rapid solution application experiment probing the same receptor pool. Because
the effect of interest could be relatively modest and/or smaller than the variation between
cells or patches recorded in separate experiments, the RASE protocol greatly enhances the
experimental design through the use of paired-sample statistics. Combined with recordings
from nucleated patches, RASE also allows experimental separation of the effects pertinent to
the intracellular machinery of receptor action on the sub-millisecond scale. In a more
general context, RASE could be applied to the fields of research outside patch-clamp
electrophysiology, such as protein-ligand interactions in biophysical or biochemical assays,
non-neuronal cell physiology or materials science.
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There are several potential limitations of RASE. First, in the case of nerve cells, this and
similar rapid application techniques are designed to probe predominantly extrasynaptic
receptors exposed to the application medium. Indeed, we have recently shown that the
externally applied concentration pulse is slowed down while reaching target receptors inside
the synaptic cleft20. Second, because of the variable characteristics of θ-glass pipettes
(profile of the tip, size of the dead space inside, widths of the two barrels and so on) such
pipettes should be individually calibrated to find a suitable pressure in each channel, the
amplitude and duration of the electric switching pulse and the recording pipette position.
Third, in nucleated patches, the turbulence at the patch side opposite to the application side
could have a variable (albeit relatively small) effect on the kinetics of recorded receptor
responses. In our experience, however, this concomitant effect could be satisfactorily
averaged out with an increased number of recorded individual traces.
Below we detail the RASE protocol setup for recording of receptor responses to sub-
millisecond application of receptor ligands. Here we routinely refer the reader to the
textbook details of brain slice preparation, whole-cell patch-clamp methods22-24, the
outside-out patch technique25 and nucleated patch configuration26 patches. Therefore,
standard electrophysiological procedures and equipment will not be discussed unless they
are specifically important to the procedure or to its troubleshooting. Substantial hands-on
experience in standard electrophysiological patch-clamp techniques is expected for a
successful implementation of the present protocol.
MATERIALS
REAGENTS
• In vitro preparation. The present protocol can be used with a variety of in vitro
preparations suitable for whole-cell recordings, from acute brain slices to cell
cultures
• Standard salts and reagents for preparing electrophysiological solutions: CaCl2,
glucose, HEPES, KCH3O3S, KCl, KOH, MgCl2, MgSO4, Na2-ATP, NaCl, Na-
GTP, NaHCO3, NaH2PO4, Na2-Phosphocreatine (all from Sigma-Aldrich)
• Deionized water, at least 15 MΩ cm at 25 °C; note that water quality is important
for recording pipette solutions
• Receptor ligands and drugs. These should be obtained from reliable sources in
accordance with the experimental design
EQUIPMENT
• A standard setup for electrophysiology, including a submerged type recording
chamber (for acute slices or cell cultures) equipped with ×20–60 IR differential
interference contrast (DIC) visualization, a patch-clamp amplifier capable of
current and voltage clamp (e.g., MultiClamp 700B), multichannel digitizer (e.g.,
Digidata 1440A), constant-voltage stimulus isolator (e.g., DS2, Digitimer) and
double-channel pneumatic drug ejector (e.g., PDES-02DX, NPI Electronics) 
CRITICAL Optimized IR DIC optics with the ×20–60 objective (with further ×2–
4 magnification) is important for visualizing neurons and reliable control of the
patch pulling process up to 100–150-μm deep inside the brain slice, where the cell
physiology is least perturbed.
• Patch electrodes pulled from borosilicate glass (e.g., GF150F-3, Warner
Instruments). Pipettes of 5–6-MΩ resistance appear to be well suited for
experiments on outside-out patches, whereas for nucleated patches the optimal
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pipette resistance is somewhat lower (4–5 MΩ); fire polishing of pipette ends
substantially increases the lifespan of a patch
• Borosilicate θ-capillary glass (e.g., TGC150-7.5, Harvard Apparatus)
• Solution loading microfilaments (e.g., MF34G, World Precision Instruments)
• Bender piezoelectric actuators with stranded wires (e.g., PL127.11, Physik
Instrumente)
• Rapidly hardening glue (e.g., cyanoacrylate glue)
PROCEDURE
Assembling the rapid application pipette  TIMING 1–2 h (excluding glue setting)
1| Pull the solution application pipette with a ~200-μm tip from θ-glass capillary
using a standard pipette puller and fix it under a low-magnification binocular
microscope, e.g., using blue tack (Fig. 1b).
2| Insert the supply microfilaments into one barrel and fix them in a position, e.g.,
with a piece of blue tack placed near the pipette blunt end (Fig. 1b).
3| Insert another freely moving microfilament connected to a syringe filled with
glue (Fig. 1b).
4| Gently eject the glue by applying pressure with the syringe; stop ejection when
the glue approaches the ends of the supply microfilaments (Fig. 1b).
 CRITICAL STEP The stop point should be at least 1.5–2-mm away from the
ends of the supply microfilaments.
This is to prevent drawing of the glue inside the filaments by capillary forces.
 TROUBLESHOOTING
5| Slowly remove the filament connected to the syringe with glue; if you
experience difficulty, leave it inside the barrel and later cut at a pipette end.
6| Repeat Steps 2–5 for the other barrel of the θ-glass pipette (Fig. 1b).
7| Leave the pipette for several hours (overnight) to let the glue set inside the
barrels (Fig. 1c).
8| Glue the piezo actuator to the holding rod and glue a pipette holder of an
appropriate size to the side of the actuator (Fig. 1d).
Assembling the pressurized solution supply system  TIMING 0.5–1 h
9| Prepare containers for the application solutions (e.g., use syringes for gravity-
driven perfusion systems or plastic containers from a standard blood dialysis kit
for closed pump-operated systems), in accordance with the number of supply
microfilaments in the θ-glass pipette (Fig. 2a,b). Equip each such container with
a tap connector and an outlet with an air-tight cap, e.g., by using thick syringe
needles glued or melted into the container body plastic (Fig. 2a,b). Place
containers in a suitable position near the recording setup.
10| Connect two groups of containers (each to supply one of the θ-glass pipette
channels) to the gas supply lines using thin tubing (e.g., Tygon 1/32-inch
tubing).
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11| In accordance with the available micropump hardware, connect the pneumatic
ejector inlets to the source of pressurized inert gas (nitrogen), and connect the
outlets to the lines supplying pressure for the two groups of containers (Fig.
2a,b).
12| Clamp the piezo-actuator rod in microelectrode holder; connect wires of the
piezo actuator to the output sockets of a constant-voltage stimulus isolator.
Insert the solution application pipette into the pipette holder; connect loading
microfilaments of the two θ-glass barrels to the corresponding groups of
containers using thin tubing (Fig. 2c).
 CRITICAL STEP Insert a microfilter connector between the container and
the loading capillary to buffer excessive pressure jumps in the system (Fig. 1d).
 TROUBLESHOOTING
System calibration and experimental setting  TIMING 2–4 h
13| To test solution exchange times, fill containers of the solution supply system
with artificial cerebrospinal fluid (ACSF) and with distilled water using syringe
inlets (Fig. 2a,b) such that each θ-glass pipette barrel can be supplied with the
alternating liquids. Apply pressure to the system to fully fill the supply
microfilaments and the pipette dead volume. Because of the different optical
characteristics of distilled water and ACSF, the corresponding ejection streams
show a visible interface and the outer boundaries; use this indicator to adjust the
recording pipette position (Supplementary Video 1). Alternatively, use different
water-soluble inert inks or dyes added to each solution.
14| Submerge the solution application pipette into the recording chamber and focus
the microscope on its tip.
15| Place the patch-clamp recording electrode filled with a standard intracellular
solution under the microscope close to the θ-glass pipette tip; open solution
supply lines so that different liquids come from the barrels. Trigger the stimulus
isolator to rapidly shift the streams near the tip of the open patch pipette.
16| Adjust the settings of the stimulus isolator (applied voltage, voltage step length),
the XYZ patch pipette position and ejection pressure at both θ-glass channels in
order to maximize the solution switch speed reflected in the recorded current
pulse (Fig. 3). Locate the optimum XYZ recording pipette tip position by
placing it near the visible stream interface.
17| Test the system for pulse lengths and solution replacement periods (inside θ-
glass barrels) in accordance with the required protocol. If the ejection stream
fails because of the unlikely event of one or more clogged channels, use other
channels or replace the application pipette.
18| Once the system has been calibrated, manipulate the recording patch pipette into
the slice (or culture) preparation. This should be done first in order to hold the
target cell in whole-cell mode and second to pull an outside-out or a nucleated
patch, in accordance with well-established electrophysiological procedures
(Supplementary Videos 2 and 3).
Protocol implementation in a patch experiment  TIMING 20–60 min
19| Place the recording pipette tip containing the patch into the optimal XYZ
position established and noted during the calibration procedure (Step 16). Start
your experiment as per your protocol.
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System maintenance  TIMING 20–30 min
20| After an experiment, thoroughly rinse the whole setup (pressurized solution
supply system, θ-glass pipette) with ~20% (vol/vol) ethanol and distilled water,
and then blow it dry with an inert gas at high pressure.
 CRITICAL STEP The θ-glass pipette tip and, especially, loading
microfilaments are extremely sensitive to blocking with dust and precipitated
crystals. Therefore, it is absolutely necessary to treat all used solutions using 4–
10-μm filters and to perform extensive rinsing after each experiment.
 TROUBLESHOOTING
 TROUBLESHOOTING
Assembling the rapid solution application set (Step 4)
The most crucial step in this preparation is the filling of θ-glass pipette with glue: capillary
forces tend to draw the glue into the loading microfilaments and also toward θ-glass pipette
tip. To overcome this, a drop of water can be placed at the sharp end of the pipette: on being
pulled into the pipette tip by capillary forces, it forms a meniscus. Because the cyanoacrylate
glue hardens rapidly upon contact with water, the water meniscus stops its progress toward
the pipette end. If the minimal dead volume is not a crucial requirement (e.g., in experiments
in which tested patches survive for longer than several minutes), filling with the glue can be
stopped near the blunt end of the θ-glass pipette.
Optimizing the pressurized solution supply system (Step 12)
When the θ-glass pipette septum is not parallel to the piezo-bending actuator and/or the
piezo-bending actuator is not perpendicular to the line of sight, it makes the system
calibration much harder. In these conditions, it becomes difficult to optimize stimulus
isolator settings and the recording pipette position (that provides a rapid enough switch
between solutions). Therefore, one should pay attention when inserting the solution
application pipette into the pipette holder and clamping the actuator rod in the
micromanipulator holder.
System maintenance (Step 20)
Small amounts of solutions tend to accumulate toward the pipette tip because of the
capillary force. It is sometimes virtually impossible to dry this remaining liquid even with
gas blowing, and precipitated crystals can sometimes block the pipette tip, thus rendering the
pipette unusable. To avoid this, after rinsing the pipette, dry it by touching its tip with a soft
(lens) paper tissue, which absorbs the remaining solution.
 TIMING
Steps 1–12, assembling a rapid solution application set: 1 d; it is recommended that 5–7 sets
should be manufactured and left overnight to let the superglue set
Steps 13–18, system calibration and experimental setting: 2–4 h, depending on the overall
quality of prepared application sets
Step 19, protocol implementation in a patch experiment: 20–60 min, depending on the
particular experimental design
Step 20, system maintenance: 20–30 min after the end of experimentation
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ANTICIPATED RESULTS
The expected results will comprise traces of the receptor current recorded from individual
outside-out or nucleated patches, normally divided into trial sweeps of 100–1,000 ms in
length (Figs. 4 and 5). These data are routinely stored offline as binary or text files for
subsequent analyses. The total number of trials per experiment is highly variable and
depends on the patch stability and the particular experimental design. With a typical signal-
to-noise ratio in this type of experimental recording, each experimental epoch (baseline-
ligand-washout) should include at least three to five individual trials to ensure appropriate
final averaging. Measured parameters of averaged traces should be analyzed using standard
statistical methods, with an advantage of having real-time pharmacological manipulations in
the same patch, thus enabling powerful paired-sample statistical tests. Normally, only one
outside-out or nucleated patch is recorded in each individual acute brain slice with the
RASE protocol, to avoid both contamination of the perfusion solution and accumulation of
applied drugs in the tissue.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Preparation of the rapid solution application pipette for RASE. (a) Schematic of the solution
application θ-glass pipette prepared for RASE (not to scale; the outer pipette diameter ~1.5
mm, the open tip diameter ~200 μm). 1: θ-glass septum, 2: section of pipette barrels filled
with glue, 3: solution supply microfilaments, 4: dead volume near the pipette tip. (b) Pipette
preparation steps. 1: pipette placed under the microscope, 2: three supply microfilaments
inserted into the right channel, 3: an additional microfilament connected to the syringe with
glue introduced (arrow), 4–6: stages depicting the right channel being filled with glue, 7:
three supply microfilaments inserted into the left channel, 8: both channels are partially
filled with glue. (c) Pipette with the solution supply microfilaments fixed inside; three
filaments and three connectors are marked black and white (unmarked) to distinguish
between the two channels. (d) Solution application pipette mounted on a piezo-actuator,
which is connected to the rod-shaped microelectrode holder. Insets 1–3 (also the dotted
circle in the top image): the plastic pipette holder made of a three-way tube connector, with
one branch cut off to provide a channel for the tightening screw, as shown (a small piece of
silicone inserted in the cutoff channel can help to dampen vibration).
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Figure 2.
The arrangement of multiple solution supply and exchange. (a,b) Two sets of three liquid
containers (plastic cylinders) connected to the pressure supply at one end (3) and to the two
θ-glass pipette channels at the other end (shown below in c). A connector inlet (1) is
connected to the solution-supplying syringe in a and closed in b. An air outlet (a thick
syringe needle embedded into the container plastic; (2)) is open during solution supply in a
and closed in b. Gas pressure lines (3) connect the two container groups to the pneumatic
ejector or micropump outlets (not shown). (c) A rapid solution application assembly
mounted near the recording chamber under a microscope objective including the θ-glass
pipette (1), the piezo-actuator (2) and an electrode holder (3), which is set in a position
above the recording chamber; six solution supply filaments are connected to the solution
supply lines (4) coming from the six corresponding containers (shown in a,b). Inset: (5) a 2-
μm microfilter inserted into the solution supply line to buffer pressure jumps in the system
while providing additional solution filtration.
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Figure 3.
Calibration and adjustment of rapid solution application. (a) Red and blue traces illustrate
responses to a rapid switch between the distilled water and the ACSF streams in θ-glass
pipette channels, before and after full solution replacement (swap over) between the two
channels (Supplementary Video 1). The panel shows a characteristic response with
suboptimal settings (pipette positioning, ejector pressure, piezo-actuator switch amplitude),
leading to characteristic concomitant relaxation waves in the system. For presentation
purposes, the currents represented by the red and blue traces were zeroed individually
(applies to a,b). (b) Rapid response under optimized (correct) settings, ensuring a sub-
millisecond application time constant (normally 150–200 μs). With the correct positioning
of the recording pipette, a time lag between the piezo-switch artifact (arrow) and the
response onset is clearly seen. Note: no deflection is seen when both pipette barrels contain
the same solution.
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Figure 4.
Examples of protocol implementation in single-channel recordings and in dose-response
rapid receptor probing. (a) Pharmacological characterization of spontaneously opening
individual GABAA receptors (single channels) in nucleated patches pulled from the dentate
gyrus granule cells (acute hippocampal slice). Successive experimental phases are shown, as
indicated: control, 25 μM gabazine, washout, 20 μM bicuculline, washout, 20 μM
picrotoxin; traces on the right are expanded fragments indicated by gray segments on the
left. Solutions in a barrel containing GABAA receptor antagonists were replaced while patch
was exposed to ACSF from another barrel (washout intervals ~15 s). (b) Statistical summary
of experiments shown in a (mean ± s.e.m.; n = 5; ***P < 0.001); see ref. 21 for further
details and explanations. Panels a and b are modified from ref. 21 with permission. (c)
Characteristic AMPAR currents in one outside-out patch of a CA1 pyramidal cell evoked by
a 1-ms pulse of 1 mM glutamate and the low-affinity antagonist γ-DGG added at four
different concentrations in successive trials, as indicated. Four filaments per θ-glass pipette
barrel were used in this experiment (each containing ACSF only, ACSF + 1 mM glutamate
and ACSF + 1 mM glutamate + one concentration of γ-DGG), and the direction of the rapid
solution switch was changed accordingly (reflected in the mirrored piezo-switch deflections)
in order to optimize the use of solution supply channels; see ref. 18 for further details and
explanations of the corresponding experimental paradigm. To avoid any residual receptor
desensitization, intertrial intervals in these and similar experiments were 10–15 s.
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Figure 5.
Examples of protocol implementations in testing mGuR-NMDAR interaction on the
millisecond time scale. (a) Top: schematic depicting how the θ-glass channel solutions are
replaced (within ~10 s) during the experiment in which the effect of blocking group I
mGluR on NMDAR activation is tested (AMPA and GABAA receptors are blocked by
antagonists present in both pipette channels throughout; see ref. 20 for further protocol
detail). The solution replacement order is as shown, from the pipette outward. Bottom:
nucleated-patch experiment in acute slices, a DIC image (recording pipette held 15–20-μm
above the slice surface) and a schematic of patch configuration (see Supplementary Video 3
for real-time illustration). (b) Traces: NMDAR currents evoked in nucleated patches of
CGCs by 1-ms pulses of 1 mM glutamate are inhibited by mGluR1s blockade (LY + MPEP)
at both negative and positive holding voltage, characteristic one-patch example; specific
NMDAR antagonist APV completely blocks the response. Graph: statistical summary (mean
± s.e.m., n = 5; ***P < 0.005). (c) Traces: similar experiment to one shown in b, but with
200 μM NMDA (which does not activate mGluRs) applied in place of glutamate; no
detectable effect of mGluR1 blockade on the NMDA-induced NMDAR response is seen.
Graph: statistical summary of the experiment, notation as in b. Figure panels are modified
from ref. 20 with permission; see the original report for further details and explanations of
experimental paradigms.
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